(Q40742257)

23 September 2017

The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line (English)

1 reference

23 September 2017

5

1 reference

23 September 2017

Laura Raimondi

4

0 references

Iacopo Sardi

object named as

Iacopo Sardi

3

0 references

Alfredo Vannacci

object named as

Alfredo Vannacci

7

0 references

author name string

Ornella Fantappiè

1

1 reference

23 September 2017

Emanuela Masini

2

1 reference

23 September 2017

Michela Solazzo

6

1 reference

23 September 2017

Roberto Mazzanti

8

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

23 September 2017

1 reference

23 September 2017

35

1 reference

23 September 2017

843-852

1 reference

23 September 2017

4

1 reference

Multidrug resistance: molecular mechanisms and clinical relevance

23 September 2017

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

P-glycoprotein and multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

Multidrug resistance in lymphomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

MDR1 (multidrug resistance) gene expression in human primary liver cancer and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

Hepatitis B surface antigen produced by a human hepatoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

Repression of inducible nitric oxide synthase and cyclooxygenase-2 by prostaglandin E2 and other cyclic AMP stimulants in J774 macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

Relaxin activates the L-arginine-nitric oxide pathway in vascular smooth muscle cells in culture.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

Metabolism of glyceryl trinitrate to nitric oxide by endothelial cells and smooth muscle cells and its induction by Escherichia coli lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

Steroid hormone receptor immunohistochemistry and amplification of c-myc protooncogene. Relationship to disease-free survival in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

Differential in vitro sensitivity of human tumor and normal cells to chemotherapeutic agents and resistance modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

Antiangiogenesis efficacy of nitric oxide donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

Endogenously produced nitric oxide inhibits endothelial cell growth as demonstrated using novel antisense cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

21 January 2018

The antioxidant paradox

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

Nitric oxide activates cyclooxygenase enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

Regulation of cyclooxygenase enzymes by nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

Nitric oxide: an inhibitor of NF-kappaB/Rel system in glial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

L-N6-(1-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

Growth factor-dependent phosphoinositide signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

Relationship of P-glycoprotein and carcinoembryonic antigen expression in human colon carcinoma to local invasion, DNA ploidy, and disease relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

Expression of the Multidrug-Resistance 1 (MDR1) Gene and Prognosis in Human Pancreatic Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

The mdrl gene, responsible for multidrug-resistance, codes for P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1053%2FJHEP.2002.32469

21 January 2018

Identifiers

DOI

10.1053/JHEP.2002.32469

1 reference

23 September 2017

1 reference